Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 06-2006 | 12-2005 | 06-2005 | 06-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 4,580 | N/A | 3,654 | 2,890 |
| Receivables | N/A | 7,639 | N/A | 3,043 | 2,336 |
| Inventories | N/A | 8,196 | N/A | 7,141 | 4,687 |
| Income taxes - deferred | N/A | 233 | N/A | 354 | 425 |
| Other current assets | 0 | 250 | 0 | 162 | 174 |
| TOTAL | $N/A | $20,898 | $N/A | $14,354 | $10,512 |
| Non-Current Assets | |||||
| PPE Net | N/A | 2,603 | N/A | 1,815 | 861 |
| Intangibles | 0 | 10,999 | 0 | 11,042 | 11,084 |
| Other Non-Current Assets | 0 | 111 | 0 | 105 | 117 |
| TOTAL | $N/A | $13,713 | $N/A | $12,962 | $12,062 |
| Total Assets | $N/A | $34,611 | $N/A | $27,316 | $22,574 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 2,389 | 0 | 2,514 | 461 |
| Accrued Expenses | N/A | 2,296 | N/A | 1,042 | 666 |
| TOTAL | $N/A | $5,843 | $N/A | $3,904 | $1,182 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $436 | $N/A | $337 | $N/A |
| Total Liabilities | $N/A | $6,279 | $N/A | $4,241 | $1,182 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 8,382 | N/A | 8,154 | 8,122 |
| Common Shares | N/A | 26,588 | N/A | 26,176 | 26,152 |
| Retained earnings | N/A | 1,744 | N/A | -3,101 | -4,760 |
| TOTAL | $N/A | $28,332 | $N/A | $23,075 | $21,392 |
| Total Liabilities And Equity | $0 | $34,611 | $0 | $27,316 | $22,574 |